Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05961215 · ClinicalTrials.gov registry record · NA
Scalp Cooling to Prevent Hair Loss in Patients Undergoing Stem Cell Transplantation for Multiple Myeloma
A NA study, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT05961215 is a NA study that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 31 participants.
The verdict
NCT05961215, a NA study, has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
This pilot study of scalp cooling with Penguin cold caps will examine the effectiveness of scalp cooling to reduce the development of hair loss in 30 participants with multiple myeloma undergoing high-dose chemotherapy with melphalan and autologous peripheral blood stem cell transplant at Cedars-Sinai Medical Center. The investigators will also assess the potential impact of hair loss versus the discomfort and inconvenience of the scalp cooling procedure.
Interventions
- DEVICE Penguin Cold Cap
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2023-08-10 |
| Est. Completion | 2025-02-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05961215
The ClinicalTrials.gov registry entry for NCT05961215 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Penguin Cold Cap is the first listed.
NCT05961215 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05961215 about?
NCT05961215 is a clinical study titled "Scalp Cooling to Prevent Hair Loss in Patients Undergoing Stem Cell Transplantation for Multiple Myeloma". This pilot study of scalp cooling with Penguin cold caps will examine the effectiveness of scalp cooling to reduce the development of hair loss in 30 participants with multiple myeloma undergoing high-dose chemotherapy with melphalan and autologous peripheral blood stem cell transplant at Cedars-Sin...
What is the current status of trial NCT05961215?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2023-08-10. Estimated completion is 2025-02-03.
What interventions are being tested in trial NCT05961215?
The interventions under investigation include: Penguin Cold Cap (DEVICE).
Who is sponsoring clinical trial NCT05961215?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.